Inhibition of stromal cell-derived factor-1α further impairs diabetic wound healing. - Wikidata - awgldk - TriplyDB

Inhibition of stromal cell-derived factor-1α further impairs diabetic wound healing.

Inhibition of stromal cell-derived factor-1α further impairs diabetic wound healing.

http://www.wikidata.org/entity/Q34679918

about

Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring Chemokines as Therapeutic Targets to Improve Healing Efficiency of Chronic Wounds Glucose toxic effects on granulation tissue productive cells: the diabetics' impaired healing.Transfusion of CXCR4-primed endothelial progenitor cells reduces cerebral ischemic damage and promotes repair in db/db diabetic mice Role of endothelial progenitor cells and inflammatory cytokines in healing of diabetic foot ulcers Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review.Akt/hypoxia-inducible factor-1α signaling deficiency compromises skin wound healing in a type 1 diabetes mouse model The role of microRNA-146a in the pathogenesis of the diabetic wound-healing impairment: correction with mesenchymal stem cell treatment.Mammalian cardiac regeneration after fetal myocardial infarction requires cardiac progenitor cell recruitment.Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue.Platelet secretion: From haemostasis to wound healing and beyond.Microenvironment in metastasis: roadblocks and supportive niches.Alginates induce differentiation and expression of CXCR7 and CXCL12/SDF-1 in human keratinocytes--the role of calcium.Role of SDF-1:CXCR4 in Impaired Post-Myocardial Infarction Cardiac Repair in Diabetes.Transplantation of stromal-derived factor 1α and basic fibroblast growth factor primed insulin-producing cells reverses hyperglycaemia in diabetic rats.

P2860

Q26778684-FA0773D5-4854-44B5-A9F3-1DC8A7A665A3 Q26778690-804D4B45-699C-48C2-B9AB-B2FE4BA42CD2 Q30428132-F1550218-8749-43BA-B00F-7847A9BA3747 Q34491057-6CF5BDB1-791F-4107-AB5B-35C171452472 Q35073067-A3F80F17-66AB-4775-93A7-65CB91F4B3E1 Q35633420-6807393C-BB6B-47E0-9534-027FA0196B7F Q35758205-8C6F4968-1EE2-479B-8E78-6737DD48EC9B Q36339633-0F776E77-8143-4CB7-BD7A-58F7FF547798 Q37280328-845396C2-7787-4B8D-8C7F-E4A3BF84B1DE Q38048249-E58DEB25-7817-4A05-B966-C692F2371592 Q38281989-7F66D3AA-4FF3-409B-AC01-76C22A1EDC3D Q38588066-14397CA6-12A6-48E0-9E74-EB0FF720EB2A Q42506905-71E30092-CE09-4B95-8C39-B067FAE704E5 Q47099846-98EC0904-868F-4AF3-91CA-1885CE498760 Q51823569-A59B3602-5319-422B-B126-C811AFFF09A8

P2860

Inhibition of stromal cell-derived factor-1α further impairs diabetic wound healing.

http://www.wikidata.org/entity/Q34679918

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Inhibition of stromal cell-derived factor-1α further impairs diabetic wound healing.

@ast

Inhibition of stromal cell-derived factor-1α further impairs diabetic wound healing.

@en

Inhibition of stromal cell-derived factor-1α further impairs diabetic wound healing.

@nl

type

label

Inhibition of stromal cell-derived factor-1α further impairs diabetic wound healing.

@ast

Inhibition of stromal cell-derived factor-1α further impairs diabetic wound healing.

@en

Inhibition of stromal cell-derived factor-1α further impairs diabetic wound healing.

@nl

prefLabel

Inhibition of stromal cell-derived factor-1α further impairs diabetic wound healing.

@ast

Inhibition of stromal cell-derived factor-1α further impairs diabetic wound healing.

@en

Inhibition of stromal cell-derived factor-1α further impairs diabetic wound healing.

@nl

P1433

Q34679918-304419CF-BF6C-450E-B2BB-26D6F2289165

P1476

Q34679918-387B6AAF-963A-474F-A43F-229C72699CAD

P2093

Q34679918-017DCE9A-61F4-41C1-B1D1-F13B0A7C9A7D

Q34679918-4B389DE8-820F-4E71-B75C-482E1C78A51F

Q34679918-6C189257-8338-45F3-BD00-63AD97D05374

Q34679918-99A2E5EE-9BA3-43EC-964A-29D976C940EF

Q34679918-A6170E1D-B981-4769-B81B-3AC5EA38F2FD

Q34679918-FA0FA066-B246-43C7-9BEA-EA89F5F8D215

P2860

Q34679918-01CD48A9-D3BF-4340-A69B-32CBBEF0B5E1

Q34679918-1161DAB1-5739-4E08-A055-B531FE9D1BB2

Q34679918-29FDF4DD-3141-46CC-8FCE-3E089912D3D7

Q34679918-2BEBA103-4590-4669-ACB2-F639789C3BA4

Q34679918-31B599CA-4C78-426E-BDD3-6FF3202BD2BA

Q34679918-353997A5-FC0E-4A20-A6F8-79B4B11EA814

Q34679918-394F9FFB-B881-4A13-9AE9-322019025F44

Q34679918-3F76C098-0A43-4B71-AE9D-119228708A80

Q34679918-3F9B3C46-4628-44F7-A47A-1C876AB09861

Q34679918-47779D34-B04C-427F-8C93-CC4CBF2A3002

P304

Q34679918-E2E76C1F-5126-4295-B947-1ECDF590AB9B

P31

Q34679918-A96F6CD9-A4C1-40AF-AE3C-1B8F9B56CEA1

P356

Q34679918-0C1F1B78-2469-47DD-A56D-57DF983AA366

P433

Q34679918-09E3729C-1A1F-4FFC-8336-8A3A52BDB9A3

P478

Q34679918-A5A7F135-D52F-4E8F-B9E4-6FC9134A296E

P577

Q34679918-1427BDE0-2483-4222-9475-45292816B092

P5875

Q34679918-9C4948B5-805C-48CB-95E9-887BBE1F0EF0

P698

Q34679918-FCAAF1A0-E43B-43BA-935B-0334412D9159

P932

Q34679918-73ECB43C-72CA-43C5-8C52-5EACFA7996B1

P356

J.JVS.2010.10.056

P1433

Journal of Vascular Surgery

P1476

Inhibition of stromal cell-derived factor-1α further impairs diabetic wound healing.

@en

P2093

Antoneta Radu

http://www.w3.org/2001/XMLSchema#string

Benjamin J Herdrich

http://www.w3.org/2001/XMLSchema#string

Dustin M Bermudez

http://www.w3.org/2001/XMLSchema#string

Junwang Xu

http://www.w3.org/2001/XMLSchema#string

Kenneth W Liechty

http://www.w3.org/2001/XMLSchema#string

Marc E Mitchell

http://www.w3.org/2001/XMLSchema#string

P2860

Hyperbaric oxygen therapy for chronic wounds

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1

Cutaneous wound healing

Unique ligand binding sites on CXCR4 probed by a chemical biology approach: implications for the design of selective human immunodeficiency virus type 1 inhibitors.

Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study.

Management and prevention of diabetic foot ulcers and infections: a health economic review.

Abnormal angiogenesis in diabetes mellitus.

Growth factors in the treatment of diabetic foot ulcers.

Endothelial progenitor cells: characterization and role in vascular biology.

P304

774-784

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JVS.2010.10.056

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49734221

http://www.w3.org/2001/XMLSchema#string

P698

21211927

http://www.w3.org/2001/XMLSchema#string

P932

3058337

http://www.w3.org/2001/XMLSchema#string